Clinical Trials Directory

Trials / Completed

CompletedNCT01509833

Efficacy of Low Dose hCG on Oocyte Maturity in Poor Responder Women Undergoing Intracytoplasmic Sperm Injection

Efficacy of Low Dose hCG on Oocyte Maturity for Ovarian Stimulation in Poor Responder Women Undergoing ICSI: a Prospective Randomized Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Royan Institute · Other Government
Sex
Female
Age
37 Years – 43 Years
Healthy volunteers
Accepted

Summary

This study is a prospective, randomized, parallel, controlled trial to assess the efficacy of the late follicular phase administration of low dose hCG on oocyte maturity for ovarian stimulation in 73 poor respond patients undergoing intracytoplasmic sperm injection (ICSI) treatment.

Detailed description

In this study all eligible patients were randomly allocated into three study groups by a permuted block randomization method: group A (control group) received only recombinant FSH, group B received rFSH supplemented by 100IU hCG in the late follicular phase. Group C received rFSH supplemented by 200IU hCG in the late follicular phase. All of the patients underwent a standard long protocol and received GnRH-a (Suprefact), 0.5cc subcutaneous, started from the day 17 of the preceding cycle and ovulation induction was started 14 days thereafter. Patients were categorized according to the following stimulation protocols: Group A (control group): which 300 IU r-FSH was administered for the first 5 days of the stimulation cycle. Then the first ultrasound scan was performed to monitor response. At this stage the dose of rFSH adjusted according to the ovarian response and continued until the day of ovulatory hCG administration. Group B: rFSH supplemented with daily administration of 100 IU hCG in the late follicular phase based on the follicle size (14mm). Group C: rFSH supplemented with daily administration of 200 IU hCG in the late follicular phase based on the follicle size (14mm). To assess the pregnancy outcomes, serum hCG was measured 2 weeks after embryo transfer. Clinical pregnancy was defined by the observation of sac with fetal heart rate on ultrasonography 4 weeks after embryo transfer.

Conditions

Interventions

TypeNameDescription
DRUGrFSHAdministration of rFSH for ovarian stimulation.
DRUGhCGAdministration of late follicular low dose hCG(100IU) for ovarian stimulation.
DRUGhCGAdministration of late follicular low dose hCG(200IU) for ovarian stimulation.

Timeline

Start date
2009-10-01
Primary completion
2011-03-01
Completion
2011-12-01
First posted
2012-01-13
Last updated
2012-01-13

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01509833. Inclusion in this directory is not an endorsement.